|
1
|
Potente M and Carmeliet P: The link
between angiogenesis and endothelial metabolism. Annu Rev Physiol.
79:43–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Usui Y, Westenskow PD, Murinello S,
Dorrell MI, Scheppke L, Bucher F, Sakimoto S, Paris LP, Aguilar E
and Friedlander M: Angiogenesis and eye disease. Annu Rev Vis Sci.
1:155–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rubio RG and Adamis AP: Ocular
angiogenesis: Vascular endothelial growth factor and other factors.
Dev Ophthalmol. 55:28–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tah V, Orlans HO, Hyer J, Casswell E, Din
N, Sri Shanmuganathan V, Ramskold L and Pasu S: Anti-VEGF therapy
and the retina: An update. J Ophthalmol. 2015:6276742015.PubMed/NCBI
|
|
5
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: Roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asghar U, Witkiewicz AK, Turner NC and
Knudsen ES: The history and future of targeting cyclin-dependent
kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allan LA and Clarke PR: Phosphorylation of
caspase-9 by CDK1/cyclin B1 protects mitotic cells against
apoptosis. Mol Cell. 26:301–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matthess Y, Raab M, Knecht R, Becker S and
Strebhardt K: Sequential Cdk1 and Plk1 phosphorylation of caspase-8
triggers apoptotic cell death during mitosis. Mol Oncol. 8:596–608.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pietenpol JA and Stewart ZA: Cell cycle
checkpoint signaling: Cell cycle arrest versus apoptosis.
Toxicology. 181:475–481. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng Y, Stauffer S, Zhou J, Chen X, Chen Y
and Dong J: Cyclin-dependent kinase 1 (CDK1)-mediated mitotic
phosphorylation of the transcriptional co-repressor Vgll4 inhibits
its tumor-suppressing activity. J Biol Chem. 292:15028–15038. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pu S, Zhao Y, Zhou G, Zhu H, Gong L, Zhang
W, Huang G, Wang D and Liu D: Effect of CDK1 shRNA on
proliferation, migration, cell cycle and apoptosis in non-small
cell lung cancer: Effect of CDK1 shRNA on NSCLC cells. J Cell
Physiol. 233:75142017.
|
|
13
|
Manchado E, Guillamot M, de Cárcer G,
Eguren M, Trickey M, García-Higuera I, Moreno S, Yamano H, Cañamero
M and Malumbres M: Targeting mitotic exit leads to tumor regression
in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α, δ
phosphatase. Cancer Cell. 18:641–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warfel NA, Dolloff NG, Dicker DT, Malysz J
and El-Deiry WS: CDK1 stabilizes HIF-1α via direct phosphorylation
of Ser668 to promote tumor growth. Cell Cycle. 12:3689–3701. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Connor KM, Krah NM, Dennison RJ, Aderman
CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL and Smith LE:
Quantification of oxygen-induced retinopathy in the mouse: A model
of vessel loss, vessel regrowth and pathological angiogenesis. Nat
Protoc. 4:1565–1573. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo T, Song H, Zhao Z, Qi Z and Zhao S:
Overexpression of Annexin A2 Receptor inhibits neovascularization
via the promotion of Krüppel-Like transcription factor 2. Cell
Physiol Biochem. 46:1617–1627. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song H, Wang W, Zhao P, Qi Z and Zhao S:
Cuprous oxide nanoparticles inhibit angiogenesis via down
regulation of VEGFR2 expression. Nanoscale. 6:3206–3216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sung WW, Lin YM, Wu PR, Yen HH, Lai HW, Su
TC, Huang RH, Wen CK, Chen CY, Chen CJ and Yeh KT: High
nuclear/cytoplasmic ratio of Cdk1 expression predicts poor
prognosis in colorectal cancer patients. BMC Cancer. 14:9512014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ronca R, Benkheil M, Mitola S, Struyf S
and Liekens S: Tumor angiogenesis revisited: Regulators and
clinical implications. Med Res Rev. 37:1231–1274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campochiaro PA: Molecular pathogenesis of
retinal and choroidal vascular diseases. Prog Retin Eye Res.
49:67–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Puro DG, Kohmoto R, Fujita Y, Gardner TW
and Padovani-Claudio DA: Bioelectric impact of pathological
angiogenesis on vascular function. Proc Natl Acad Sci USA.
113:9934–9939. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simó R and Hernandez C: Intravitreous
anti-VEGF for diabetic retinopathy: Hopes and fears for a new
therapeutic strategy. Diabetologia. 51:15742008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao H, Tian M, Ge J, Wei X, Li Z, Li X,
Tao D, Hu J and Gong J: The role of CDK1 siRNA interference in cell
cycle and cell apoptosis. Front Med China. 3:3842009. View Article : Google Scholar
|
|
25
|
Rattani A, Vinod PK, Godwin J,
Tachibana-Konwalski K, Wolna M, Malumbres M, Novák B and Nasmyth K:
Dependency of the spindle assembly checkpoint on Cdk1 renders the
anaphase transition irreversible. Curr Biol. 24:630–637. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang SH, Kim AR, Park NH, Park JW and Han
IS: DRG2 regulates G2/M progression via the cyclin B1-Cdk1 complex.
Mol Cells. 39:699–704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Fan M, Candas D, Zhang TQ, Qin L,
Eldridge A, Wachsmann-Hogiu S, Ahmed KM, Chromy BA, Nantajit D, et
al: Cyclin B1/Cdk1 coordinates mitochondrial respiration for
cell-cycle G2/M progression. Dev Cell. 29:217–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang P, Kawakami H, Liu W, Zeng X,
Strebhardt K, Tao K, Huang S and Sinicrope FA: Targeting CDK1 and
MEK/ERK overcomes apoptotic resistance in BRAF-mutant human
colorectal cancer. Mol Cancer Res. 16:378–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang R, Shi H, Ren F, Zhang M, Ji P, Wang
W and Liu C: The aberrant upstream pathway regulations of CDK1
protein were implicated in the proliferation and apoptosis of
ovarian cancer cells. J Ovarian Res. 10:602017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karimian A, Ahmadi Y and Yousefi B:
Multiple functions of p21 in cell cycle, apoptosis and
transcriptional regulation after DNA damage. DNA Repair (Amst).
42:63–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi LW, Zhang Z, Zhang CF, Anderson S, Liu
Q, Yuan CS and Wang CZ: Anti-colon cancer effects of 6-shogaol
through G2/M cell cycle arrest by p53/p21-cdc2/cdc25A crosstalk. Am
J Chin Med. 43:743–756. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J: The cell-cycle arrest and
apoptotic functions of p53 in tumor initiation and progression.
Cold Spring Harb Perspect Med. 6:a0261042016. View Article : Google Scholar : PubMed/NCBI
|
